サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1405969

多毛症の市場規模、シェア、動向分析レポート：治療タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Hirsutism Market Size, Share & Trends Analysis Report By Treatment Type (Medications, Procedures), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
多毛症の市場規模、シェア、動向分析レポート：治療タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2023年12月12日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

多毛症市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の多毛症市場規模は2030年までに50億米ドルに達し、2024年から2030年までのCAGRは7.2％で拡大すると予測されています。

多毛症市場は、現在蔓延しているCOVID-19の大流行によってマイナスの影響を受けています。2021年9月のNCBIの記事によると、Yaleらによる研究では、多嚢胞性卵巣症候群（PCOS）を含む高アンドロゲン女性、多毛症、COVID-19の関連を調査しました。

この研究では、高アンドロゲン症のCOVID-19陽性女性の入院率は4.5％から8％であり、これらの疾患のない女性では11.4％から11.7％であったのに比べ、死亡率の有意な上昇は認められません。さらに、これらの女性におけるCOVID-19感染や入院の発生率は、スピロノラクトン、エストラジオール、メトホルミンなどの治療薬の使用と有意な関連はないようでした。

レーザー脱毛の需要は、美容施術の増加や美容意識の高まりにより、特に市場において増加しています。レーザー脱毛は、ムダ毛とそれに関連する美容的・心身的懸念に対する最も一般的な解決策です。国際美容整形学会によると、2022年、脱毛施術は美容治療の主要な部分を占め、女性・男性合わせて180万件以上の施術が行われました。この脱毛施術の増加は、ムダ毛に対する効果的かつ恒久的な解決策への需要を浮き彫りにしています。

多毛症市場レポートハイライト

  • 多毛症の治療に使用される最も一般的な薬剤は低容量ピルのため、2023年の治療タイプセグメントで56.8％以上のシェアを占めているのは薬剤です。
  • 処置セグメントは予測期間中最も速いCAGRで成長する見込みです。
  • 上唇セグメントは2023年に25.6％の最大市場シェアを占めました。顎セグメントは予測期間中に大きく成長すると予測されています。顎の外側の角や上唇に薄い産毛が生えている女性は一般的であり、多毛症の有病率の上昇に寄与しています。
  • 北米は、多毛症の有病率の増加、購買力平価の高さ、質の高いヘルスケアに対する政府の支援、償還の利用可能性などの要因により、多毛症市場を独占しています。
  • 2022年10月、非腫瘍性疾患および腫瘍性疾患に対する非常に効果的で低侵襲的、非侵襲的、費用対効果の高い治療を専門とする医療機器メーカーであるセンサス・ヘルスケアは、波長をブレンドした可動式シルク・バイ・センサス脱毛システムを発表しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 多毛症の市場変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 多毛症市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 多毛症市場：治療タイプの推定・動向分析

  • 治療タイプの市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 治療タイプ別の世界の多毛症市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
    • 薬剤
    • 処置
    • その他

第5章 多毛症市場：用途の推定・動向分析

  • 用途の市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 用途別の世界の多毛症市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
    • 上唇
    • 顎
    • 胸
    • 腕
    • その他

第6章 多毛症市場：最終用途の推定・動向分析

  • 最終用途の市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の多毛症市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
    • 病院
    • 皮膚科クリニック・エステティックセンター
    • その他

第7章 多毛症市場：地域の推定・動向分析

  • 地域の市場シェア分析、2023年および2030年
  • 地域の市場ダッシュボード
  • 世界の地域の市場スナップショット
  • 市場規模、予測および動向分析、2018年から2030年まで
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Ajanta Pharma
    • Alma Lasers Ltd.
    • Alpaya Dermaceuticals
    • Cynosure Inc.
    • Lumenis Inc.
    • Nisim Inc.
    • Sciton International
    • Koninklijke Philips NV
    • Merck &Co., Inc.
    • Pfizer Inc.
    • Cutera Inc.
    • El.En. SpA
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of secondary sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Hirsutism market: market outlook
  • Fig. 14 Hirsutism competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Hirsutism market driver impact
  • Fig. 20 Hirsutism market restraint impact
  • Fig. 21 Hirsutism market strategic initiatives analysis
  • Fig. 22 Hirsutism market: Treatment type movement analysis
  • Fig. 23 Hirsutism market: Treatment type outlook and key takeaways
  • Fig. 24 Medications market estimates and forecast, 2018 - 2030
  • Fig. 25 Procedures market estimates and forecast, 2018 - 2030
  • Fig. 26 Others market estimates and forecast, 2018 - 2030
  • Fig. 27 Hirsutism Market: Application movement Analysis
  • Fig. 28 Hirsutism market: Application outlook and key takeaways
  • Fig. 29 Upper Lip market estimates and forecasts, 2018 - 2030
  • Fig. 30 Chin market estimates and forecasts,2018 - 2030
  • Fig. 31 Chest market estimates and forecasts,2018 - 2030
  • Fig. 32 Arms market estimates and forecasts,2018 - 2030
  • Fig. 33 Others market estimates and forecasts,2018 - 2030
  • Fig. 34 Hirsutism market: End-use movement analysis
  • Fig. 35 Hirsutism market: End-use outlook and key takeaways
  • Fig. 36 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 37 Dermatology Clinics & Aesthetic Centers market estimates and forecasts,2018 - 2030
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030
  • Fig. 39 Global Hirsutism market: Regional movement analysis
  • Fig. 40 Global Hirsutism market: Regional outlook and key takeaways
  • Fig. 41 Global Hirsutism market share and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America, by country
  • Fig. 53 North America
  • Fig. 54 North America market estimates and forecasts, 2018 - 2030
  • Fig. 55 U.S.
  • Fig. 56 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 57 Canada
  • Fig. 58 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 59 Europe
  • Fig. 60 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 61 UK
  • Fig. 62 UK market estimates and forecasts, 2018 - 2030
  • Fig. 63 Germany
  • Fig. 64 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 65 France
  • Fig. 66 France market estimates and forecasts, 2018 - 2030
  • Fig. 67 Italy
  • Fig. 68 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 69 Spain
  • Fig. 70 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 71 Denmark
  • Fig. 72 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 73 Sweden
  • Fig. 74 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 75 Norway
  • Fig. 76 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 77 Asia Pacific
  • Fig. 78 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 79 China
  • Fig. 80 China market estimates and forecasts, 2018 - 2030
  • Fig. 81 Japan
  • Fig. 82 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 83 India
  • Fig. 84 India market estimates and forecasts, 2018 - 2030
  • Fig. 85 Thailand
  • Fig. 86 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Korea
  • Fig. 88 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 89 Australia
  • Fig. 90 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 91 Latin America
  • Fig. 92 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 93 Brazil
  • Fig. 94 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 95 Mexico
  • Fig. 96 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 97 Argentina
  • Fig. 98 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 99 Middle East and Africa
  • Fig. 100 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 101 South Africa
  • Fig. 102 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 103 Saudi Arabia
  • Fig. 104 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 105 UAE
  • Fig. 106 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 107 Kuwait
  • Fig. 108 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 109 Market share of key market players- Hirsutism market
目次
Product Code: GVR-4-68040-166-3

Hirsutism Market Growth & Trends:

The global hirsutism market size is anticipated to reach USD 5.0 billion by 2030 and is anticipated to expand at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market for hirsutism has been negatively affected by the COVID-19 pandemic, which is now widespread. According to the NCBI article in September 2021, a study by Yale et al. examined the connection between hyperandrogenic women, including those with polycystic ovary syndrome (PCOS), hirsutism, and COVID-19.

The study revealed that hospitalization among COVID-19-positive women with hyperandrogenism ranged from 4.5% to 8%, with no significant boost in mortality rates compared to 11.4%-11.7% in those without these conditions. In addition, the incidence of COVID-19 infection or hospitalization in these women did not appear to be significantly associated with their use of therapeutic agents, including spironolactone, estradiol, and metformin.

The demand for laser hair removal is growing, especially in the markets, due to an increasing number of cosmetic procedures and rising consciousness about beauty. Laser hair removal is the most commonly used solution for unwanted hair and its associated cosmetic and psychosomatic concerns as individuals strive for smooth, hairless skin. In 2022, hair removal procedures were a major part of aesthetic treatments, with over 1.8 million operations conducted by women and men, according to the International Society for Aesthetic Plastic Surgery. This increase in hair removal procedures highlights the demand for an effective and permanent solution to unwanted hair.

Hirsutism Market Report Highlights:

  • Medications dominated the treatment type segment with more than 56.8% share in 2023, owing to birth control pills the most common medications used to treat hirsutism
  • The procedures segment is expected to grow at the fastest CAGR over the forecast period
  • The upper lip segment held the largest market share of 25.6% in 2023. The chin segment is anticipated to grow significantly over the forecast period. It is common for women to have light facial hair on the exterior corners of the jawline and upper lip, contributing to the growing prevalence of hirsutism
  • North America dominated the market for hirsutism owing to factors such as increasing the prevalence of hirsutism, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
  • In October 2022, Sensus healthcare a medical device manufacturer specializing in highly effective, minimally-invasive, non-invasive, and cost-operative treatments for non-oncological conditions and oncological, introduced its movable silk by sensus hair removal system with blended wavelengths

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment type
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Type
    • 2.2.2. Application
    • 2.2.3. End-use
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hirsutism Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of hirsutism among women
      • 3.2.1.2. Cosmetic and psychology problems associated with unwanted hair
      • 3.2.1.3. Rising prevalence of polycystic ovary syndrome
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the laser hair removal procedures
  • 3.3. Hirsutism Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Hirsutism Market: Treatment Type Estimates & Trend Analysis

  • 4.1. Treatment type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Hirsutism Market by Treatment Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Medications
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Procedures
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Hirsutism Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Hirsutism Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Upper Lip
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Chin
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Chest
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Arms
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Hirsutism Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Hirsutism Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Dermatology Clinics & Aesthetic Centers
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Hirsutism Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Ajanta Pharma
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Alma Lasers Ltd.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Alpaya Dermaceuticals
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Cynosure Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Lumenis Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Nisim Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Sciton International
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Koninklijke Philips N.V
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Merck & Co., Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Pfizer Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Cutera Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. El.En. S.p.A.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives